Axa’s LifeVantage LFVN Stock Holding History

Axa’s Portfolio LFVN Stock Details LFVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,337	Closed	-$117K	–	1271
2020 Q1	$117K	Hold	11,337	–	–	﹤0.01%	1134
2019 Q4	$177K	Sell	11,337 -21,063	-65%	-$310K	﹤0.01%	1136
2019 Q3	$444K	Sell	32,400 -800	-2%	-$9.76K	﹤0.01%	1115
2019 Q2	$431K	Buy	+33,200	New	+$395K	﹤0.01%	1098

Other funds holding LFVN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Axa's LFVN Position: Q2 2020 in Review

Axa sold out of LifeVantage (LFVN) in Q2 2020, closing a stake of 11,337 shares — an estimated $117K sold.

Axa first reported a position in LFVN in Q2 2019 and held it in 4 quarters. The position peaked at $444K in Q3 2019. 83 funds tracked by Wall St. Rank hold LFVN as of Q2 2020.

Axa reported no remaining LifeVantage position as of Q2 2020 after selling out during the quarter.
Axa sold 11,337 LifeVantage shares in Q2 2020, an estimated $117K.
Axa first reported a position in LifeVantage in Q2 2019 and held it in 4 quarters.
Axa's LifeVantage position peaked at $444K in Q3 2019.
83 funds tracked by Wall St. Rank held LifeVantage as of Q2 2020.

Based on Axa's 13F filing for Q2 2020, filed 14 Aug 2020.